Paper Details

  1. Home
  2. Paper Details

[The investigation on the safety and immunogenicity of inactived hepatitis A vaccine AVAXIM].

Author: HuangG, LiR, WanZ

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

AVAXIM, an inactivated hepatitis A vaccine, is safe and immunogenic in both children and adults. After two doses, the vaccine resulted in seroconversion rates of 98.15% in children and 94.17% in adults. The most common side effect was local pain.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To investigate the safety and immunogenicity of AVAXIM in children and adults. METHODS: One hundred and twenty-one children aged 6 - 12 years and 108 adults with negative HAV antibody, were inoculated by 0, 6 month procedure with inactivated HAV vaccine produced by Pasteur Merieux Conna...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/11860802

データ提供：米国国立医学図書館（NLM）

AVAXIM: A Safe and Immunogenic Hepatitis A Vaccine

Hepatitis A, a viral infection that affects the liver, can cause serious illness and complications. Vaccination is a crucial tool in preventing this disease. This study investigates the safety and immunogenicity of AVAXIM, an inactivated hepatitis A vaccine, in both children and adults. The researchers conducted a clinical trial to evaluate the effectiveness and side effect profile of AVAXIM.

AVAXIM: Effective and Safe Hepatitis A Vaccine

The study showed that AVAXIM was both safe and immunogenic in both children and adults. The researchers observed a high rate of antibody development after vaccination, indicating that the vaccine was effective in generating a protective immune response. The side effects were mild and localized, with no serious systemic or local reactions reported.

Protecting Against Hepatitis A: A Vital Public Health Measure

This study reinforces the importance of vaccination in preventing hepatitis A. The findings demonstrate that AVAXIM is a safe and effective vaccine that can help protect individuals from this potentially serious disease. The study highlights the vital role of vaccination in public health efforts to control infectious diseases.

Dr.Camel's Conclusion

This study is a testament to the power of vaccines in protecting against infectious diseases. AVAXIM is a valuable tool in the fight against hepatitis A, offering a safe and effective way to protect both children and adults from this potentially serious condition. It’s like a shield against the harsh desert winds of infection.

Date :
  1. Date Completed 2004-11-02
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

11860802

DOI: Digital Object Identifier

11860802

Related Literature

Article Analysis
・Side Effects of hepatitis a vaccine
SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.